These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 17679791)

  • 21. Combination therapy with insulin and oral agents: optimizing glycemic control in patients with type 2 diabetes mellitus.
    Yki-Järvinen H
    Diabetes Metab Res Rev; 2002; 18 Suppl 3():S77-81. PubMed ID: 12324990
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Barriers to achieving glycemic targets: who omits insulin and why?
    Weinger K; Beverly EA
    Diabetes Care; 2010 Feb; 33(2):450-2. PubMed ID: 20103561
    [No Abstract]   [Full Text] [Related]  

  • 23. Insulin therapy in type 2 diabetes.
    Mudaliar S; Edelman SV
    Endocrinol Metab Clin North Am; 2001 Dec; 30(4):935-82. PubMed ID: 11727406
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prevalence of diabetes treated with drugs in Andalucía. Evolution of the oral antidiabetics and insulin prescription between 1994 and 2000].
    Torrecilla Rojas MA; Ríos Bonin C; Fernández Fernández I
    Rev Clin Esp; 2003 Sep; 203(9):426-9. PubMed ID: 14563255
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between serum alkaline phosphatase and C-reactive protein in the United States National Health and Nutrition Examination Survey 2005-2006.
    Webber M; Krishnan A; Thomas NG; Cheung BM
    Clin Chem Lab Med; 2010 Feb; 48(2):167-73. PubMed ID: 19958209
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic syndrome therapy: prevention of vascular injury by antidiabetic agents.
    Dominguez LJ; Sowers JR
    Curr Hypertens Rep; 2005 Apr; 7(2):110-6. PubMed ID: 15748534
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High prevalence of metabolic risk factors for cardiovascular diseases among Saudi population, aged 30-64 years.
    Rahman Al-Nuaim A
    Int J Cardiol; 1997 Dec; 62(3):227-35. PubMed ID: 9476683
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of trimethoprim-sulfamethoxazole on blood insulin and glucose concentrations of diabetics.
    Mihic M; Mautner LS; Feness JZ; Grant K
    Can Med Assoc J; 1975 Jun; 112(13 Spec No):80-2. PubMed ID: 1137831
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of colesevelam in patients with type 2 diabetes mellitus and inadequate glycemic control receiving insulin-based therapy.
    Goldberg RB; Fonseca VA; Truitt KE; Jones MR
    Arch Intern Med; 2008 Jul; 168(14):1531-40. PubMed ID: 18663165
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evolving strategies for insulin delivery and therapy.
    Cefalu WT
    Drugs; 2004; 64(11):1149-61. PubMed ID: 15161324
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hypoglycemic therapy in heart disease patients with type 2 diabetes mellitus].
    Cosmi F; Cosmi D
    G Ital Cardiol (Rome); 2010 Jun; 11(6):460-6. PubMed ID: 20922871
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LEADER 5: prevalence and cardiometabolic impact of obesity in cardiovascular high-risk patients with type 2 diabetes mellitus: baseline global data from the LEADER trial.
    Masmiquel L; Leiter LA; Vidal J; Bain S; Petrie J; Franek E; Raz I; Comlekci A; Jacob S; van Gaal L; Baeres FM; Marso SP; Eriksson M;
    Cardiovasc Diabetol; 2016 Feb; 15():29. PubMed ID: 26864124
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prevalence of diabetes, antidiabetic treatment and chronic diabetic complications reported by general practitioners].
    Fabian W; Majkowska L; Stefański A; Moleda P
    Przegl Lek; 2005; 62(4):201-5. PubMed ID: 16229234
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The glycemic response to a test breakfast of an enteral diet with fiber and a high starch content in diabetics treated with insulin and oral antidiabetics].
    Sanz París A; Peg V; Gamboa RA; Playán Usón J; Acha Pérez FJ; Casamayor Peris L; Celaya Pérez S
    Nutr Hosp; 1993 Nov; 8(8):465-70. PubMed ID: 8280804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiovascular risk profile in individuals with borderline glycemia: the effect of the 1997 American Diabetes Association diagnostic criteria and the 1998 World Health Organization Provisional Report.
    Lim SC; Tai ES; Tan BY; Chew SK; Tan CE
    Diabetes Care; 2000 Mar; 23(3):278-82. PubMed ID: 10868851
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vascular disease in diabetes and the effect of oral antidiabetic agents.
    Marble A
    Adv Metab Disord; 1973; 2():Suppl 2:539-47. PubMed ID: 4720384
    [No Abstract]   [Full Text] [Related]  

  • 37. Income Disparities in Absolute Cardiovascular Risk and Cardiovascular Risk Factors in the United States, 1999-2014.
    Odutayo A; Gill P; Shepherd S; Akingbade A; Hopewell S; Tennankore K; Hunn BH; Emdin CA
    JAMA Cardiol; 2017 Jul; 2(7):782-790. PubMed ID: 28593301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical outcomes in metabolic syndrome.
    Bhatheja R; Bhatt DL
    J Cardiovasc Nurs; 2006; 21(4):298-305. PubMed ID: 16823284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
    Krentz AJ; Bailey CJ
    Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Nutritional and metabolic status and dietetic evaluation in institutionalized elderly patients with non-insulin-dependent diabetes mellitus].
    Casimiro C; García de Lorenzo A; Usán L;
    Nutr Hosp; 2001; 16(3):104-11. PubMed ID: 11475679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.